Scanbur A Slash S
Scanbur A/S, headquartered in Denmark (DK), is a prominent player in the pharmaceutical and biotechnology industry, specialising in the development and production of high-quality veterinary medicines and nutritional products. Founded in 1985, the company has established a strong presence in Europe and beyond, focusing on innovative solutions that enhance animal health and welfare. With a diverse portfolio that includes vaccines, antibiotics, and nutritional supplements, Scanbur A/S is recognised for its commitment to quality and efficacy. The company’s unique approach combines advanced research with a deep understanding of animal needs, positioning it as a trusted partner in the veterinary sector. Notable achievements include significant contributions to animal health standards and a growing market share, solidifying Scanbur A/S's reputation as a leader in veterinary pharmaceuticals.
DitchCarbon Score
How does Scanbur A Slash S's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Business Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Scanbur A Slash S's score of 6 is lower than 85% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Scanbur A Slash S's reported carbon emissions
Scanbur A/S, headquartered in Denmark, has set ambitious climate commitments aimed at significantly reducing its greenhouse gas emissions. Although specific emissions data for the most recent year is not available, the company has established a target to reduce its Scope 1 and Scope 2 emissions by 42% by 2030, using 2022 as the base year. This target has been validated through the Science Based Targets initiative (SBTi), ensuring alignment with the necessary reductions to limit global warming to 1.5°C. In addition to its focus on direct emissions (Scope 1 and 2), Scanbur A/S is also committed to measuring and reducing its Scope 3 emissions, which encompass indirect emissions throughout its value chain. This comprehensive approach reflects the company's dedication to addressing its overall carbon footprint within the pharmaceuticals, biotechnology, and life sciences sector. As a small to medium-sized enterprise, Scanbur A/S's targets are particularly noteworthy, as they demonstrate a proactive stance in climate action, contributing to broader sustainability goals within the industry.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Scanbur A Slash S is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
